Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-25T00:43:09.414Z Has data issue: false hasContentIssue false
  • English
  • Français

MRI Findings of Adult Maple Syrup Urine Disease Exacerbation

Published online by Cambridge University Press:  23 September 2014

Sapna Rawal ,
Hanna Faghfoury  and
Timo Krings
Sapna Rawal*
Affiliation:
Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada
Hanna Faghfoury
Affiliation:
University Health Network, University of Toronto, Toronto, Ontario, Canada Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Timo Krings
Affiliation:
University Health Network, University of Toronto, Toronto, Ontario, Canada
*
Department of Medical Imaging, University of Toronto, Fitzgerald building, Room 112, 150 College Street, Toronto Ontario, M5S 3e2, Canada. Email: sapna.rawal@hotmail.com.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 2 , March 2013 , pp. 259 - 262
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Chuang, D, Shih, V. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver, C, Beaudet, A, Sly, W, Valle, D, editors. The metabolic & molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 1971.Google Scholar
2. Naylor, E. Newborn screening in maple syrup urine disease (branched-chain ketoaciduria). In: Augustin, AV, Bickel, H, Guthrie, R, Hammersen, G, editors. Neonatal screening for inborn errors of metabolism. New York: Springer-Verlag; 1980. p. 19.Google Scholar
3. Quental, S, Vilarinho, L, Martins, E, et al. Incidence of maple syrup urine disease in Portugal. Mol Genet Metab. 2010 Aug;100(4):385–7. Epub 2010 Apr 22.CrossRefGoogle ScholarPubMed
4. Carleton, SM, Peck, DS, Grasela, J, Dietiker, KL, Phillips, CL. DNA carrier testing and newborn screening for maple syrup urine disease in old order Mennonite communities. Genet Test Mol Biomarkers. 2010 Apr;14(2):205–8.Google Scholar
5. Parmar, H, Sitoh, YY, Ho, L. Maple syrup urine disease: Diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Assist Tomogr. 2004 Jan-Feb;28(1):93–7.Google Scholar
6. Zinnanti, WJ, Lazovic, J, Griffin, K, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009 Apr;132(Pt 4):903–18.Google Scholar
7. Sutter, R, Killer, HE, Bilz, S, et al. Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease. Eur J Neurol. 2009 Mar;16(3):e45–6.Google Scholar
8. Jan, W, Zimmerman, RA, Wang, ZJ, Berry, GT, Kaplan, PB, Kaye, EM. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology. 2003 Jun;45(6):393–9.Google Scholar